chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine clinic held on 1/21/21. Vaccination provided by  pharmacist.  Patient received a vaccination at this clinic.  On 1/22/21 patient reported to her supervisor she went to the doctor because her injection site became hard, hot and red and was given an antibiotic for an possible infection.
- chills body aches, head ache  - 6 days later nausea and vomiting  - dehydrated that caused kidney stones  - was at ER then referred to neurologist, to see if it was migraine related or brain disease
Blurry Vision; Irregular heartbeats; Low heart rate "41-47"; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EW0176) via an unspecified route of administration in the left arm on 16May2021 at 11:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, asthma and penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 11:10, the patient experienced irregular heartbeats, Low heart rate "41-47" detected on apple watch series 6, this happened 10min after injection and subsided about 1hour later.  On16May2021 at 17:30, the patient experienced blurry vision. She was fasting for 18hours at time of injection, but drinking plenty of water. Therapeutic measures were taken as a result of AE(s) and included treatment with cold compress and a bottle of water. The clinical outcome of the event irregular heartbeats, low heart rate "41-47" was recovered on 16May2021 at 12:10. The clinical outcome of the event blurry vision was unknown at time of this report.  No follow-up attempts are needed. No further information is expected.
Pt rcd flu vaccine on 11/26, went to ER on 11/27 with facial swelling and rash bilat upper arms and neck. All sx resolved with IV abx. Pt instructed to never get flu shot again.
both my wife and i got vaccinations at the same time a both came down with severe upper respiratory infections at the same time .We do not normally have  "colds '' much any more and were both bed ridden for several days . We read of the concern that measles can weaken immune response  and wanted to report this as it might indicate a relationship.   We are both on the mend now but wanted to give a heads up about it .
Vasovagal syncope.  A few moments after vaccine patients mother brought her to counter and stated she was wobbly and blacking out.  We took her to waiting area and raised her legs and called 911.  By time paramedics arrived her color was returning and she was much better. Paramedics observed her for a bit and advised mom to take her to urgent care to have her checked over.
About four months later, in June, I began to feel very weak, dizzy and short of breath. Those symptoms progressed so I decided to seek help since I don't have healthcare. I had a blood test done - with immediate results. My Hemoglobin was at a 6.4. And I was taken by ambulance by the Health clinic to the Hospital ER. I haven't been able to work, etc. There was no treatment post ER. I have had two follow up visits and bloodwork done and my Hemoglobin stays at a 9.1 and it needs to be 12 - 15.  Weakness, dizziness and the profound exhaustion are still happening daily.
Headache; Chills; Nausea; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration on 06Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced headache, chills and nausea; all (non-serious) on Feb2021. Consumer said that she had her Pfizer COVID-19 vaccine second shot on Saturday, and was calling today to find out how long she should expect the headaches, chills, and nausea feeling to last, or at what time should she be alarmed with these. Caller declined to complete a report. No further details captured, reported, or documented at this time. The outcome of events was unknown.    Information about Batch/Lot number has been requested.
I had the usual fatigue and muscle pain the evening of the 1st dose and lasted three days. By the fourth day I was feeling okay but was feeling vertigo. On the fourth day the tinnitus kicked in. I also had tenderness under right armpit and breast. The tinnitus and vertigo have persisted.
Starting the evening of my shot, I started feeling fatigued and fever, just felt flu like symptoms. 3 week after vaccination I started having super high blood pressure and heart palpitations. Called my PCP they advised me to just watch my blood pressure, progressively it got lower and went away.
My first period after getting the shot started around my normal cycle day but it was one day shorter than normal. I now have started another period 10 days after my period ended which is highly abnormal and has never before happened to me. My cycles are normally 28-34 days and have never been shorter than about 26 days. After reading many other stories from woman having issues with their periods (usually just the one following the shot) after getting vaccinated I believe it may be vaccine related as I have never had an issue and it is occurring during the period immediately following the shot. I do note that I had no irregularities with my first 2 shots.
He had his Vivid shot and awoke blind in left eye 4 hours later.  Went to ER and then on Friday went to eye Dr. at clinic.
Itching on arms, legs, neck, chest and back. I itch so much and so bad that I had red looking blood like red spots on my arms and legs. Also bruises on my arms and legs from scratching so much. I had to take benadryl  at night and use benadryl cream during the day while at work. This started the evening I received the COVID Vaccine and I didn't stop itching until March 29th.
Medication error in which the vial of vaccine was diluted with 0.18 ml instead of 1.8 ml of normal saline. Resulting in the employee receiving a higher dose of the vaccine.
Patient c/o of nausea and tongue feeling numb.  Hives noted across face and redness on chest.  Patient placed on side, gave Epinephrine .4cc IM.  Called 911. EMT's arrive at 3:25pm.  EMT's transferred patient to hospital at 3:40.  Follow Up Done 10/3/2012 and patient released from hospital approximately 6:00pm after observation according to RN.  Patient back to work today 10/3/2012.
On 12/23/2022 I had a hard time breathing, short of breath. I also had lung congestion and coughing. I went to the emergency room and they stated I had some PVC but I had PVC since 2016. I went to feeling better and I went home. Then event occurred on 01/22/2023 and I went to the emergency room again for the same symptoms and they referred me to a cardiologist. They also provided me with medications anthramycin and inhaler. I am following up with the cardiologist. I'm now on a heart monitor for 30 day.
Scattered erythema raised lesions - 2 crusted, others between vesicular -> flat- <10, varicella reaction to vaccine.
Swollen injection site; Sore injection site; Swollen lymph nodes in left armpit and left neck/clavicle; Cold sweats; Headache; Fever; chills; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via an unspecified route of administration in the left arm on 17Apr2021 at 14:00 as a single dose for COVID-19 immunisation. Medical history included allergy to wasp/hornet stings and anomalous pulmonary veins. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin D nos (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), fish oil (MANUFACTURER UNKNOWN), and probiotics (MANUFACTURER UNKNOWN) ) from an unknown date for an unknown indication and unknown if ongoing. The patient received other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732) via an unspecified route of administration in the right arm on 27Mar2021 as a single dose for COVID-19 immunisation. On 18Apr2021 at 09:00, the patient experienced fever, chills, cold sweats, headache, sore injection site, swollen injection site, swollen lymph nodes in left armpit and left neck/clavicle. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, cold sweats, headache, sore injection site, swollen injection site, swollen lymph nodes in left armpit and left neck/clavicle was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected
Within 24 hrs of receiving the FLUZONE injection in his right deltoid, patient developed an approximate 10cm x 15cm large, red, swollen, hot to touch area below injection site. Placed on KEFLEX on 10/11/15 for cellulitis by urgent care.
opened IPOL was exposed to temperature of 50.9 F due to refrigerator door was left open (human error) and the product was administered to a patient with no reported adverse event; opened IPOL was exposed to temperature of 50.9 F due to refrigerator door was left open (human error) and the product was administered to a patient with no reported adverse event; Initial information received on 01-Aug-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves opened IPV (VERO) [Ipol] which was exposed to temperature of 50.9 F due to refrigerator door was left open (human error) and was administered to patient of unknown age and gender with no reported adverse event.  On an unknown date patient received an opened ipol (Suspension for injection) (lot: V18891M; expiry date: 01-Jan-2024) (strength, route, administration site unknown) which was exposed to temperature of 50.9 F due to refrigerator door was left open (human error) with no reported adverse event (product storage error) (unknown latency) (poor quality product administered) (latency: same day).  It was reported, "Does extended stability data cover the excursion? No for opened IPOL If negative advice, was the product administered to a patient? Yes There is data to support the excursion of daptacel, adacel, pentacle, tenivac and ACTHIB but for the opened IPOL, stability over the recommendation was not yet evaluated."   Action taken was not applicable.  At time of reporting, the outcome was Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pfizer COVID vaccine EUA: Fully vaccinated patient presented with a 1-day history of body aches, head pressure and headache
No adverse effects; unspecified patients received improperly stored doses of PNEUMOVAX 23; This spontaneous report was received from a medical assistant, referring to a 68-year-old patient of unknown gender. No information regarding the patient's pertinent medical histories, concurrent conditions, concomitant therapies, drug reactions or allergies.  It was reported that on 09-OCT-2019, the vaccine pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was exposed to a temperature excursion with a lowest temperature below 36 Fahrenheit (F) degrees (30.5 F degrees) for 10 hours. There was no previous temperature excursions.  On 01-NOV-2019, the patient was vaccinated with the improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # S029265, expiration date 31-MAR-2021 (dose, dose number, route of administration and anatomical injection site were not reported) for prophylaxis. The call was placed because of the Digital Data logger report. No adverse effects reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: S029265; expirationdate: 31-MAR-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-1911USA001801: US-009507513-2005USA002426: US-009507513-2005USA002452: US-009507513-2005USA002453: US-009507513-2005USA002454: US-009507513-2005USA002455: US-009507513-2005USA002456:
(L) arm pain and numbness, felt like "my throat was closing" "my chest was tight." Flushed face and (L) arm. Used ice pack to treat (L) arm pain. Reported to ER on 9/25/15 at 730pm w/c/o "fever (99.8) shaking" and pain all over." Treated with albuterol nebulizer and then sent home. 9/26/15 "felt sore from shaking from fever" had taken TYLENOL x3 (325,g) by mouth.
Injection Friday 2/16, Saturday 2/27 afternoon, common symptoms, fever, chills, muscle aches. Sunday 2/28 through Monday Tuesday 3/2 nausea; Wednesday 3/3 vomiting, Thursday 3/4 nausea, Friday 3/5 nausea, Saturday vomited 2 times went to emergency room, Sunday 3/7 - Wednesday 3/10 nausea, Thursday vomiting, still nauseous.
From 12/4 visit:  HPI: Pt received immunizations on Monday. Yesterday they started to have redness and swelling at injections sites on both legs.  Pt has a lot of pain in both legs and is limping. Legs are itching and keeping pt awake during the night. Exam: anterior thighe on teh Rt with idnuration of 4cm and erythema extends to 10cm , on the Lt induration about 5cm however on the medial side there are lenear collection of vesicles, clear in a ring ~5.5 cm..the erythema extends to 12 cm diameter..slightly tender..  From 12/6 f/u visit: HPI: Received Pentacel and Prevnar #4 12/2 4 days ago Pentacel on left and Prevnar on right  very large area of erythema, warmth, induration, and blisters with left worse than right   seen 2 days ago and instructed to give Zyrtec fever 100.2 starting 2 days ago   didn't sleep well last 2 nights otherwise wnl appetite and activity, gait was affected, better today   parents concerned about allergy and future ramifications Exam:left anterior lateral thigh with 12 cm x 10 cm pen outline with mostly resolving pink macular and 1 cm area of induration at visible puncture site lateral thigh, right anterior thigh with 10.5 cm x 7 cm pen outline also with resolving macular pink within it and similar 1 cm area of induration, no warmth, no edema, and NT either thigh, flattened semi circle of vesicles on left anterior thigh, nl gait
Pt. described immediate urticaria and pruritic, followed by diffuse, transient neuropathies and some difficulty breathing and wheezing. Denied any throat/facial swelling.
flu like symptoms; This is a spontaneous report from a contactable Nurse. A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "flu like symptoms".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a registered nurse regarding a 10 year old patient of unknown gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medication were not reported. On 02-OCT-2017, the patient was vaccinated with one improperly stored dose of PROQUAD subcutaneously (strength, anatomical location, dose number, lot number and expiration date were not provided) for prophylaxis. The PROQUAD was stored at a temperature range of 15 degrees Fahrenheit (°F) to 46 °F for the time frame of 5 hours. There was no previous temperature excursion and the call was not because of a data logger. No adverse effects reported. This is one of nine reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA013247: US-009507513-1710USA013248: US-009507513-1710USA013249: US-009507513-1710USA013250: US-009507513-1710USA013251: US-009507513-1710USA013252: US-009507513-1710USA013253: US-009507513-1710USA001718:
3 days post vaccination, patient reported multiple ulcers in her mouth, on her tongue and sides of cheeks and inside of lips, no previous history or reports of any flares/cases of HSV1.  4 days post vaccination, patient reported significant tongue swelling, did not interfere with breathing, however, swallowing was difficult.  Patient was given Benedryl by parent and reported to pediatrician for counseling on 2nd dose of vaccine.
Mother reported child was dizzy and vomiting, with a slight fever (she didn't actually take the temp, but reported that he "felt hot."
G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/10/2023 ACUTE STROKE DUE TO EMBOLISM OF LEFT CAROTID ARTERY I63.9 ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY 4/12/2023 ACUTE STROKE DUE TO EMBOLISM OF LEFT CAROTID ARTERY
Shot administered 12:45PM 10/8/08.  Awoke at 5AM 10/9/08 feeling dizzy and feverish.  Headache and joint aches about 8AM. A coworker that received vaccine at same time did not experience any ill effects.
None at time of this VAERS. 7 mos. old patient was given 1/2 of a pre-filled 0.5 ml dose syringe. It was later discovered there are separate 0.25 pre-filled indicated for those under 4 yrs.
22JUL91 mom reported on this day that following pt immun 10JUN91 devel fever of 103 R w/APAP & cried a lot, had local rxn both thighs; worse on lt;
14:33 99% RA, HR 88. Epi given @ 14:34 L leg, 14:35 99% RA, HR 81, BP 130/76. 14:41 HR 77, Resp 22, BP 103/64 O2 99% RA.  14:54 BP 104/67, 99% RA HR 70. EMS arrived @ 1500. Pt refused. Education given. 15:03 escorted Pt to car.
REDNESS AND SWELLING WITH DISCOMFORT DUE TO SWELLING RANGING FROM INJECTION SITE DOWN TO ELBOW.
The patient received his vaccine on Tuesday, 2/2/21. The patient did not complain of any ADRs or fever immediately following the injection. However, the next day he had a temperature of 100.2 F. Since the patient was febrile, he was given rapid COVID tests, which was negative. Patient received acetaminophen. He was not in distress. He had no complaints otherwise.
2 small blisters - one on each thigh. (R) thigh approx 1 inch from needle mark anterior. (L) lateral thigh, approx 2 inches from needle site. No redness, no signs of infection.
Muscle & joint pain not relieved with TYLENOL. Burning pain especially in head. Not had any fever. Pain has been continuous since Nov. 8th (now 78 days).
After receiving the vaccine, I felt nothing. 2 ½ months later, I had appendicitis. On 8/29, I had pain that got worse. I wen to the ER on 8/30 around 2:00. By 6:00am, my appendix was out and all is well. I am able to return to work tomorrow.
Joint pain; Fever; can't walk for two days after; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunization, reaction(s): "Joint pain", "Can't walk for two days after"; Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization, reaction(s): "Fever"; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 Immunization, reaction(s): "Joint pain"; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 immunization, reaction(s): "Can't walk for two days after", "Fever"; Bnt162b2 (DOSE 3 (BOOSTER), SINGLE), administration date: Jul2022, for Covid-19 immunization, reaction(s): "Joint pain", "Can't walk for two days after", "Fever". The following information was reported: ARTHRALGIA (non-serious), outcome "unknown", described as "Joint pain"; PYREXIA (non-serious), outcome "unknown", described as "Fever"; GAIT DISTURBANCE (non-serious), outcome "unknown", described as "can't walk for two days after".  Additional Information:Narrative case summary and further information Submitted. Reporter was related to study or programme. Confirmed that Patient was the reporter. Reason for no lot number of Pfizer COVID-19 vaccine was Complainant hung up abruptly/transfer incomplete. Confirmed that bivalent Pfizer COVID-19 vaccine was Pfizer product.Attempted transfer from (Name withheld) with Pfizer Program Support Call Center of consumer who mentioned she got her first shot of booster last July, and also her last shot will be in the month of September. She experienced some weird reactions: joint pain, fever, and can't walk for two days after, and for each of three consecutive doses she had the same reaction. Caller also had an inquiry, and asked if vaccines are FDA approved. Agent gave answer to that, caller wanted more clarification for regards to that. He provided her the number for Pfizer Medical Information. Agent clarified caller already got bivalent COVID-19 vaccine and experienced the same reaction like she experienced with her last two or three doses. Agent said caller got her first booster in July.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201160812 Same reporter/events/patient, different products; Report 3 of 4;US-PFIZER INC-202201160811 Same reporter/events/patient, different products; Report 2 of 4;US-PFIZER INC-202201160813 Same reporter/events/patient, different products; Report 4 of 4;
Numb and tingling right foot at bedtime. The next morning right foot was numb on the bottom outer area and pinky toe and the next two toes.
This spontaneous report was received from a physician regarding a 13 year old male patient with no pertinent medical history or drug reactions or allergies. On 28-JUN-2013 the patient was vaccinated with GARDASIL (lot number and expiration date not reported) (dose and route not reported) for immunization. Other suspect therapies included MANTOUX SKIN TEST administered intradermally on 28-JUN-2013. There was no concomitant medications. The physician reported that the mother of the patient believed that the concurrent administration of GARDASIL and MANTOUX SKIN TEST that were both administered during an office visit, may have caused her son to have a positive PPD test on 01-JUL-2013. The physician prescribed the patient Isoniazid and ordered a chest x-ray to be obtained as soon as possible to determine if the PPD result wsa a false positive or not. Outcome for the PPD test positive was unknown at the time of the report. Additional information has been requested.
On April 16 had absence seizure.  I have not had one in over 7 months and felt no warning or precursors.    That night fatigue, chills (freezing) headache, nausea, foggy thinking, tense shoulder neck muscles, foot cramps.  Day of 17th (ongoing) fatigue, tense shoulders/neck/ lack of hunger, foggy thinking, headache went away with Ibuprofen and Tylenol.  Have ate yet so unsure of nausea.
Generalized rash, possible seizure (without fever) on 9/12/09.